| 2023 | Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial
| JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEW ENGLAND JOURNAL OF MEDICINE |
| 2020 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
| NEW ENGLAND JOURNAL OF MEDICINE |
| 2020 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer | NEW ENGLAND JOURNAL OF MEDICINE |
| 2022 | Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer | NEW ENGLAND JOURNAL OF MEDICINE |
| 2017 | Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study | LANCET ONCOLOGY |
| 2010 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. | LANCET |
| 2023 | Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer - Authors' reply | LANCET GASTROENTEROLOGY & HEPATOLOGY |
| 2023 | Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14) | LANCET GASTROENTEROLOGY & HEPATOLOGY |
| 2023 | Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2018 | Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2023 | Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial
| ECLINICALMEDICINE |
| 2023 | Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin-Reply | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2013 | Treating rheumatoid arthritis to target: recommendations assessment questionnaire in Korea | CLINICAL RHEUMATOLOGY |
| 2018 | Treatment and clinical outcomes of elderly idiopathic membranous nephropathy: A multicenter cohort study in Korea | ARCHIVES OF GERONTOLOGY AND GERIATRICS |
| 2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2020 | Treatment modification after second-line failure among people living with HIV in the Asia-Pacific
| ANTIVIRAL THERAPY |
| 2021 | Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver
| ISCIENCE |
| 2002 | Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. | BRITISH JOURNAL OF SURGERY |
| 2022 | Treatment of advanced heart failure
| JOURNAL OF THE KOREAN MEDICAL ASSOCIATION(대한의사협회지) |
